International Medical Center of Biomaterials Processing and Cryostorage (MOEX: GEMA)
Russia
· Delayed Price · Currency is RUB
672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
GEMA Statistics
Total Valuation
International Medical Center of Biomaterials Processing and Cryostorage has a market cap or net worth of RUB 10.03 billion. The enterprise value is 10.03 billion.
Market Cap | 10.03B |
Enterprise Value | 10.03B |
Important Dates
The last earnings date was Tuesday, November 12, 2024.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
International Medical Center of Biomaterials Processing and Cryostorage has 14.93 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 14.93M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.43% |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.55.
Current Ratio | 2.31 |
Quick Ratio | 2.25 |
Debt / Equity | 0.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.10% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -1.10% |
50-Day Moving Average | 694.16 |
200-Day Moving Average | 852.67 |
Relative Strength Index (RSI) | 38.85 |
Average Volume (20 Days) | 778 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 225.57 million in cash and 237.87 million in debt, giving a net cash position of -12.30 million or -0.82 per share.
Cash & Cash Equivalents | 225.57M |
Total Debt | 237.87M |
Net Cash | -12.30M |
Net Cash Per Share | -0.82 |
Equity (Book Value) | 434.69M |
Book Value Per Share | n/a |
Working Capital | 171.96M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 8.65, which amounts to a dividend yield of 1.29%.
Dividend Per Share | 8.65 |
Dividend Yield | 1.29% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 1.29% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |